Sinonasal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Sinonasal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with cetuximab for recurrent/metastatic head and neck squamous cell carcinoma; the stu…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating the addition of M6620 (berzosertib; VX-970) to standard chemotherapy and radiation for head and neck cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 trial evaluating the combination of pembrolizumab and cabozantinib in head and neck squamous cell carcinoma reported results, with r…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma [Phase 1]
A Phase 1 trial evaluating birinapant in combination with intensity-modulated re-irradiation therapy for locally recurrent head and neck squ…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 study evaluating chemotherapy with or without bevacizumab for recurrent or metastatic head and neck squamous cell carcinoma; results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.